Most Recent
RMIT has been hit with a $2.9 million lawsuit by an Indigenous law professor who claims he was fired for complaining about "racially and sexually discriminatory remarks" allegedly made by one of the university's senior officials.
Law firm Clayton Utz and litigation funder Investor Claim Partners have joined forces to bring a class action against insurers who have denied business interruption claims by business impacted by the COVID-19 pandemic.
The publisher of The Australian has settled defamation proceedings brought by celebrity chef Jock Zonfrillo, just a few months after the lawsuit was filed.
The daughter of property data pioneer Ray Catelan has won a legal fight with Excelsior shareholders over claims she acquired a controlling share of the real estate private equity firm while in possession of inside information that caused a dramatic spike in the company's share price after it went public.
A former portfolio manager of IOOF has sued the firm for discrimination and breaches of the Fair Work Act, alleging she was groped on the breasts by a high ranking senior executive on her wedding day.
A judge has shot down a bid by Nine, the ABC and a high-profile journalist to use articles reporting on Dr Chau Chak Wing's $280,000 defamation victory as evidence mitigating the harm to his reputation from a report at the centre of a separate defamation case.
A trade mark dispute between US oil giant Chevron and Australian petrol station operator Ampol has been set down for an expedited hearing in April, ahead of which the companies have been ordered into mediation.
At least five law firms are investigating lawsuits, including class action proceedings, in the wake of a landmark test case on COVID-19 exclusions for business interruption cover.
The Fair Work Commission has found a Bank of Queensland manager was unfairly dismissed despite making a "careless" mistake which led to a fraudster nabbing nearly $40,000 of a customer's money.
Pfizer unit Wyeth is seeking to overturn part of a judge's decision in its high-stakes patent dispute with Merck Sharp & Dohme that found claims in two of its patents relating to the blockbuster Prevnar 13 pneumococcal vaccine were invalid.